Issues
First issue features:
- Our first overview article published in Toxicologic Pathology
 - Key regulatory discussions, including engagement with major regulatory authorities
 - Highlights from our first public webinars, with more than 170 and 120 participants
 - Meet the people behind VICT3R in our new interview series
 - Expanding industry and academic collaborations to advance VCGs
 
Check out the web version.